ESALF (Eisai Co) Cyclically Adjusted FCF per Share: $2.04 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ESALF Eisai Co Ltd ESALF
75 GF Score
Price $31.55
GF Value $32.40
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Eisai Co Cyclically Adjusted FCF per Share?

Eisai Co ESALF 75 Cyclically Adjusted FCF per Share is $2.04 as of Jun. 2026. GuruFocus rates ESALF with a GF Score™ of 75/100 and a GF Value™ of $32.40 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Eisai Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was $-0.152. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $2.04 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Eisai Co's average Cyclically Adjusted FCF Growth Rate was -9.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -7.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -3.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Eisai Co was 9.00% per year. The lowest was -7.10% per year. And the median was 0.50% per year.

As of today (2026-09-22), Eisai Co's current stock price is $31.55. Eisai Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $2.04. Eisai Co's Cyclically Adjusted Price-to-FCF of today is 15.49.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Eisai Co was 15.40. The lowest was 4.77. And the median was 9.10.


Eisai Co  (OTCPK:ESALF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Eisai Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=31.55/2.037
=15.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Eisai Co was 15.40. The lowest was 4.77. And the median was 9.10.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Eisai Co Cyclically Adjusted FCF per Share Related Terms


Eisai Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Eisai Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eisai Co Cyclically Adjusted FCF per Share Chart

Eisai Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.76 2.49 2.33 2.23 2.07

Eisai Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 2.11 2.14 2.01 2.04

ESALF vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Eisai Co's Cyclically Adjusted Price-to-FCF falls into.


ESALF
75GF Score
Eisai Co Ltd ESALF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eisai Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eisai Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.152/113.6000*113.6000
=-0.152

Current CPI (Jun. 2026) = 113.6000.

Eisai Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 1.029 98.000 1.193
201612 0.398 98.400 0.459
201703 0.861 98.100 0.997
201706 -0.222 98.500 -0.256
201709 0.447 98.800 0.514
201712 0.749 99.400 0.856
201803 3.511 99.200 4.021
201806 0.303 99.200 0.347
201809 1.113 99.900 1.266
201812 0.233 99.700 0.265
201903 1.060 99.700 1.208
201906 -0.273 99.800 -0.311
201909 0.317 100.100 0.360
201912 0.583 100.500 0.659
202003 2.175 100.300 2.463
202006 0.039 99.900 0.044
202009 0.152 99.900 0.173
202012 0.064 99.300 0.073
202103 1.543 99.900 1.755
202106 -0.841 99.500 -0.960
202109 2.313 100.100 2.625
202112 -0.226 100.100 -0.256
202203 1.086 101.100 1.220
202206 -0.206 101.800 -0.230
202209 -0.791 103.100 -0.872
202212 -0.324 104.100 -0.354
202303 0.680 104.400 0.740
202306 0.103 105.200 0.111
202309 0.315 106.200 0.337
202312 0.016 106.800 0.017
202403 0.544 107.200 0.576
202406 -0.273 108.200 -0.287
202409 0.159 108.900 0.166
202412 -0.065 110.700 -0.067
202503 0.605 111.100 0.619
202506 -0.084 111.700 -0.085
202509 0.452 112.000 0.458
202512 0.712 113.000 0.716
202603 -0.041 112.700 -0.041
202606 -0.152 113.600 -0.152

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $2.04 mean?
Eisai Co (ESALF) has a Cyclically Adjusted FCF per Share of $2.04 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Eisai Co and its competitors.
Is Eisai Co's Cyclically Adjusted FCF per Share too high?
Eisai Co's current Cyclically Adjusted FCF per Share is $2.04. Overall, Eisai Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's Cyclically Adjusted FCF per Share compare to ZTS?
Eisai Co's Cyclically Adjusted FCF per Share of $2.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Eisai Co and its competitors. Eisai Co's current Cyclically Adjusted FCF per Share is $2.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (ESALF) is currently considered Fairly Valued. The stock's GF Value™ is $32.40, compared to a current price of $31.55 — trading 2.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $2.04. Eisai Co's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Eisai Co (ESALF), the current Cyclically Adjusted FCF per Share is $2.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eisai Co (ESALF) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of $31.55 is trading 2.6% below its estimated GF Value™ of $32.40. GuruFocus considers Eisai Co to be Fairly Valued.

Key valuation signals for ESALF:

  • Cyclically Adjusted FCF per Share: $2.04
  • GF Value™: $32.40 vs. price of $31.55 (2.6% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the ESALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co., Ltd. is a Japanese pharmaceutical company focused on neurology and oncology, with additional franchises in gastrointestinal and other therapeutic areas. Its best-known products include lecanemab (Leqembi), developed with Biogen for Alzheimer's disease, and the anticancer agent lenvatinib (Lenvima), partnered with Merck. Eisai also markets proton pump inhibitors and other medicines, and operates a consumer healthcare business in Japan. The company conducts research, development, manufacturing, and sales through subsidiaries and partners worldwide, organized around regions including Japan, the Americas, Europe, the Middle East, Africa, Russia, Oceania, China, and broader Asia. Revenue comes from prescription drug sales, licensing and collaboration arrangements, and consumer products, with North America and Japan among its largest markets. Eisai emphasizes its human health care philosophy and reinvests heavily in research and development.
75GF Score

Get the complete analysis for ESALF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.55
Price
$32.40
GF Value